Nanda Bondade
Examiner (ID: 1930)
Most Active Art Unit | 2912 |
Art Unit(s) | 2902, 2900, 2912 |
Total Applications | 5029 |
Issued Applications | 4983 |
Pending Applications | 0 |
Abandoned Applications | 46 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17334576
[patent_doc_number] => 20220000907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => MOUTHWASH/GARGLE, NASAL/ORAL/NASAL SPRAY COVID AND BACTERIOCIDE ARRANGEMENT
[patent_app_type] => utility
[patent_app_number] => 17/189455
[patent_app_country] => US
[patent_app_date] => 2021-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7157
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17189455
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/189455 | MOUTHWASH/GARGLE, NASAL/ORAL/NASAL SPRAY COVID AND BACTERIOCIDE ARRANGEMENT | Mar 1, 2021 | Abandoned |
Array
(
[id] => 16899109
[patent_doc_number] => 20210178025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES
[patent_app_type] => utility
[patent_app_number] => 17/188634
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6145
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188634
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/188634 | ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES | Feb 28, 2021 | Abandoned |
Array
(
[id] => 16898838
[patent_doc_number] => 20210177754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => NANOEMULSION FOR ORAL USE
[patent_app_type] => utility
[patent_app_number] => 17/185087
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16153
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185087
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/185087 | NANOEMULSION FOR ORAL USE | Feb 24, 2021 | Pending |
Array
(
[id] => 19134593
[patent_doc_number] => 11969502
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Oral products
[patent_app_type] => utility
[patent_app_number] => 17/183580
[patent_app_country] => US
[patent_app_date] => 2021-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 23164
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17183580
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/183580 | Oral products | Feb 23, 2021 | Issued |
Array
(
[id] => 17050517
[patent_doc_number] => 20210259951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => Transmucosal Drug Delivery System
[patent_app_type] => utility
[patent_app_number] => 17/177430
[patent_app_country] => US
[patent_app_date] => 2021-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17177430
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/177430 | Transmucosal Drug Delivery System | Feb 16, 2021 | Pending |
Array
(
[id] => 16990058
[patent_doc_number] => 20210228478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => TRANEXAMIC ACID SPRAY FOR KNEE ARTHROPLASTY
[patent_app_type] => utility
[patent_app_number] => 17/169403
[patent_app_country] => US
[patent_app_date] => 2021-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169403
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/169403 | TRANEXAMIC ACID SPRAY FOR KNEE ARTHROPLASTY | Feb 5, 2021 | Pending |
Array
(
[id] => 16990058
[patent_doc_number] => 20210228478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => TRANEXAMIC ACID SPRAY FOR KNEE ARTHROPLASTY
[patent_app_type] => utility
[patent_app_number] => 17/169403
[patent_app_country] => US
[patent_app_date] => 2021-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169403
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/169403 | TRANEXAMIC ACID SPRAY FOR KNEE ARTHROPLASTY | Feb 5, 2021 | Pending |
Array
(
[id] => 17005271
[patent_doc_number] => 20210236432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => COMPOSITIONS COMPRISING ROFLUMILAST FOR TREATING HIDRADENITIS SUPPURATIVA AND PRURIGO NODULARIS
[patent_app_type] => utility
[patent_app_number] => 17/166336
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6365
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17166336
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/166336 | COMPOSITIONS COMPRISING ROFLUMILAST FOR TREATING HIDRADENITIS SUPPURATIVA AND PRURIGO NODULARIS | Feb 2, 2021 | Abandoned |
Array
(
[id] => 16853362
[patent_doc_number] => 20210154107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => PARTICLES CONTAINING COLORING AGENTS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/164308
[patent_app_country] => US
[patent_app_date] => 2021-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23610
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17164308
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/164308 | PARTICLES CONTAINING COLORING AGENTS AND METHODS OF USING THE SAME | Jan 31, 2021 | Pending |
Array
(
[id] => 16990633
[patent_doc_number] => 20210229053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => AMINO ACID SURFACTANTS
[patent_app_type] => utility
[patent_app_number] => 17/154919
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154919
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/154919 | AMINO ACID SURFACTANTS | Jan 20, 2021 | Pending |
Array
(
[id] => 17290839
[patent_doc_number] => 20210386678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => BIOPOLYMER-ENCAPSULATED GLYCOSYL TRANSFERASE INHIBITOR COMPOSITIONS AND METHODS FOR TREATING DIABETES AND CARDIAC INDICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/152708
[patent_app_country] => US
[patent_app_date] => 2021-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17152708
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/152708 | BIOPOLYMER-ENCAPSULATED GLYCOSYL TRANSFERASE INHIBITOR COMPOSITIONS AND METHODS FOR TREATING DIABETES AND CARDIAC INDICATIONS | Jan 18, 2021 | Abandoned |
Array
(
[id] => 18232076
[patent_doc_number] => 11596618
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-07
[patent_title] => Oral cannabinoid delivery formulations with mouthfeel experience enhancers
[patent_app_type] => utility
[patent_app_number] => 17/150418
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15675
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150418
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/150418 | Oral cannabinoid delivery formulations with mouthfeel experience enhancers | Jan 14, 2021 | Issued |
Array
(
[id] => 16961596
[patent_doc_number] => 20210213095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => COMPOSITIONS AND METHODS FOR ACTIVATING CELLULAR SIGNALING PATHWAYS
[patent_app_type] => utility
[patent_app_number] => 17/148448
[patent_app_country] => US
[patent_app_date] => 2021-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17148448
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/148448 | COMPOSITIONS AND METHODS FOR ACTIVATING CELLULAR SIGNALING PATHWAYS | Jan 12, 2021 | Abandoned |
Array
(
[id] => 17748275
[patent_doc_number] => 20220226478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => FILM-FORMING COMPOSITION CONTAINING GELLAN GUM AND STARCH, AND APPLICATION IN SOFT CAPSULE
[patent_app_type] => utility
[patent_app_number] => 17/614644
[patent_app_country] => US
[patent_app_date] => 2020-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614644
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/614644 | FILM-FORMING COMPOSITION CONTAINING GELLAN GUM AND STARCH, AND APPLICATION IN SOFT CAPSULE | Dec 27, 2020 | Pending |
Array
(
[id] => 16930883
[patent_doc_number] => 20210196772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => CONFECTIONS FOR SKIN PROTECTION: COMPOSITIONS, METHODS FOR MAKING, AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/133460
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17133460
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/133460 | CONFECTIONS FOR SKIN PROTECTION: COMPOSITIONS, METHODS FOR MAKING, AND APPLICATIONS THEREOF | Dec 22, 2020 | Abandoned |
Array
(
[id] => 16976124
[patent_doc_number] => 20210220361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/133094
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17133094
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/133094 | SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR | Dec 22, 2020 | Abandoned |
Array
(
[id] => 17576974
[patent_doc_number] => 20220133829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => ANTIVIRAL COMPOSITIONS AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/127589
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6665
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127589
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/127589 | Antiviral compositions and methods of using same | Dec 17, 2020 | Issued |
Array
(
[id] => 16914073
[patent_doc_number] => 20210187165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => Collagen Tissue Modification
[patent_app_type] => utility
[patent_app_number] => 17/122392
[patent_app_country] => US
[patent_app_date] => 2020-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17122392
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/122392 | Collagen Tissue Modification | Dec 14, 2020 | Pending |
Array
(
[id] => 17655190
[patent_doc_number] => 20220175655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => CALLUS LYSATE COMPRISING HIGH CONTENT OF CALLUS METABOLITE AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/112591
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112591
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/112591 | Callus lysate comprising high content of callus metabolite and preparation method thereof | Dec 3, 2020 | Issued |
Array
(
[id] => 16898977
[patent_doc_number] => 20210177893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => Composition and method for treating and healing Medication-Related Osteonecrosis of the Jaw (MRONJ)
[patent_app_type] => utility
[patent_app_number] => 17/110249
[patent_app_country] => US
[patent_app_date] => 2020-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17110249
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/110249 | Composition and method for treating and healing Medication-Related Osteonecrosis of the Jaw (MRONJ) | Dec 1, 2020 | Abandoned |